Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ned Tijdschr Geneeskd ; 1652021 05 06.
Artigo em Holandês | MEDLINE | ID: mdl-34346577

RESUMO

Three immunocompetent children were admitted to the hospital because of varicella-related complications. The first patient developed a bacterial pneumonia secondary to a varicella infection which ultimately lead to a debridement using Video Assisted Thoracoscopic Surgery. The second patient presented with a left peripheral facial paralysis and vesicular lesions in de left auricle. Liquor investigations were positive for the varicella zoster virus and she was diagnosed with Ramsay Hunt syndrome. The last patient was referred to the emergency department with possible absence seizures. These seizures turned out to be caused by an ischemic stroke due to post-varicella arteriopathy. All patients were previously healthy and had no risk factors for varicella-related complications. We conclude that varicella-related complications should also be considered in immunocompetent children, even when the primary infection took place months ago. Patients with severe varicella-related complications need to be referred to a medical specialist where anti-viral therapy should be considered.


Assuntos
Varicela , Paralisia Facial , Varicela/complicações , Criança , Feminino , Herpesvirus Humano 3 , Hospitalização , Humanos , Fatores de Risco
2.
Gut ; 70(7): 1266-1274, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-33046558

RESUMO

OBJECTIVE: The aim of this study was to describe the long-term health outcomes of children born to mothers with inflammatory bowel disease (IBD) and to assess the impact of maternal IBD medication use on these outcomes. DESIGN: We performed a multicentre retrospective study in The Netherlands. Women with IBD who gave birth between 1999 and 2018 were enrolled from 20 participating hospitals. Information regarding disease characteristics, medication use, lifestyle, pregnancy outcomes and long-term health outcomes of children was retrieved from mothers and medical charts. After consent of both parents, outcomes until 5 years were also collected from general practitioners. Our primary aim was to assess infection rate and our secondary aims were to assess adverse reactions to vaccinations, growth, autoimmune diseases and malignancies. RESULTS: We included 1000 children born to 626 mothers (381 (61%) Crohn's disease, 225 (36%) ulcerative colitis and 20 (3%) IBD unclassified). In total, 196 (20%) had intrauterine exposure to anti-tumour necrosis factor-α (anti-TNF-α) (60 with concomitant thiopurine) and 240 (24%) were exposed to thiopurine monotherapy. The 564 children (56%) not exposed to anti-TNF-α and/or thiopurine served as control group. There was no association between adverse long-term health outcomes and in utero exposure to IBD treatment. We did find an increased rate of intrahepatic cholestasis of pregnancy (ICP) in case thiopurine was used during the pregnancy without affecting birth outcomes and long-term health outcomes of children. All outcomes correspond with the general age-adjusted population. CONCLUSION: In our study, we found no association between in utero exposure to anti-TNF-α and/or thiopurine and the long-term outcomes antibiotic-treated infections, severe infections needing hospital admission, adverse reactions to vaccinations, growth failure, autoimmune diseases and malignancies.


Assuntos
Fármacos Gastrointestinais/uso terapêutico , Infecções/epidemiologia , Doenças Inflamatórias Intestinais/tratamento farmacológico , Neoplasias/epidemiologia , Complicações na Gravidez/epidemiologia , Efeitos Tardios da Exposição Pré-Natal/epidemiologia , Adalimumab/uso terapêutico , Adulto , Antibacterianos/uso terapêutico , Doenças Autoimunes/epidemiologia , Cesárea/estatística & dados numéricos , Desenvolvimento Infantil/fisiologia , Pré-Escolar , Anormalidades Congênitas/epidemiologia , Prescrições de Medicamentos/estatística & dados numéricos , Quimioterapia Combinada , Feminino , Humanos , Lactente , Recém-Nascido , Recém-Nascido Pequeno para a Idade Gestacional , Infecções/tratamento farmacológico , Infliximab/uso terapêutico , Mercaptopurina/análogos & derivados , Mercaptopurina/uso terapêutico , Países Baixos/epidemiologia , Admissão do Paciente/estatística & dados numéricos , Gravidez , Nascimento Prematuro/epidemiologia , Estudos Retrospectivos , Inibidores do Fator de Necrose Tumoral/uso terapêutico , Vacinas/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA